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Abstract: Oxidative stress has been considered universally and undeniably implicated in 
the pathogenesis of all major diseases, including those of the cardiovascular system. 
Oxidative stress activate transcriptional messengers, such as nuclear factor—κB, tangibly 
contributing to endothelial dysfunction, the initiation and progression of atherosclerosis, 
irreversible damage after ischemic reperfusion, and even arrhythmia, such as atrial 
fibrillation. Evidence is rapidly accumulating to support the role of reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) as intracellular signaling molecules. Despite 
this connection between oxidative stress and cardiovascular disease (CVD), there are 
currently no recognized therapeutic interventions to address this important unmet need. 
Antioxidants that provide a broad, “upstream” approach via ROS/RNS quenching or free 
radical chain breaking seem an appropriate therapeutic option based on epidemiologic, 
dietary, and in vivo animal model data. Short-term dietary intervention trials suggest that 
diets rich in fruit and vegetable intake lead to improvements in coronary risk factors and 
reduce cardiovascular mortality. Carotenoids are such abundant, plant-derived, fat-soluble 
pigments that functions as antioxidants. They are stored in the liver or adipose tissue, and 
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are lipid soluble by becoming incorporated into plasma lipoprotein particles during 
transport. For these reasons, carotenoids may represent one plausible mechanism by which 
fruits and vegetables reduce the risk of chronic diseases as cardiovascular disease (CVD). 
This review paper outlines the role of carotenoids in maintaining cardiac health and 
cardioprotection mediated by several mechanisms including redox signaling. 
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1. Introduction 
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) play important roles in 
regulation of cell survival. In general, moderate levels of ROS/RNS may function as signals to 
promote cell proliferation and survival, whereas severe increases of ROS/RNS can induce cell death. 
Under physiologic conditions, the balance between generation and elimination of ROS/RNS maintains 
the proper function of redox-sensitive signaling proteins. Normally, the redox homeostasis ensures that 
the cells respond properly to endogenous and exogenous stimuli. However, when the redox 
homeostasis is disturbed, oxidative stress may lead to aberrant cell death and contribute to disease 
development [1]. Oxidative damage by free radicals has been well investigated within the context of 
oxidant/antioxidant balance. Indeed, oxidative stress describes various deleterious processes resulting 
from an imbalance between the excessive formation of reactive oxygen and/or nitrogen species and 
limited antioxidant defenses [2]. In this regard, cardiovascular risk factors significantly cause oxidative 
stress, which contributes to a disruption in the balance between nitric oxide (NO) and reactive oxygen 
species, with a resulting relative decrease in NO bioavailability. The resulting endothelial dysfunction 
has been supposed to be the first step of atherosclerosis. Further, majority of cardiovascular diseases 
follow from complications of atherosclerosis. In addition, an important initiating event for 
atherosclerosis may well be the transport of oxidized low-density lipoprotein across the endothelium 
into the artery wall [3–5]. 
In the post-ischemic myocardium, elevated levels of exogenous ROS are generated in cardiomyocytes, 
endothelial cells, and infiltrating neutrophils that can lead to cellular dysfunction and necrosis. ROS 
most likely contribute to the pathogenesis of myocardial infarction (MI) and serve as mediators of the 
reversible ventricular dysfunction (stunning) that often accompanies reperfusion of ischemic 
myocardium. Nutritional epidemiologic research demonstrates that those who consume higher 
amounts of fruits and vegetables tend to have lower rates of heart and vascular diseases, including 
coronary heart disease and stroke [6]. Carotenoids present in fruits and vegetables may prevent heart 
and vascular disease in a number of ways. The present review outlines the role of various carotenoids 
in cardiac health and cardioprotection mediated by several mechanisms including redox signaling. 
2. Mechanisms of Redox Signaling 
Redox signaling plays a pivotal role in many disorders—for example, vascular smooth muscle 
proliferation, atherosclerosis, angiogenesis, cardiac hypertrophy, fibrosis, remodeling [7]. ROS may Molecules 2012, 17 4757 
 
induce acute (that is, over seconds to minutes) alterations in cellular functions via specific covalent 
modifications of target molecules. For example, key proteins involved in myocardial excitation-contraction 
coupling, such as sarcolemmal ion channels, sarcoplasmic reticulum calcium release channels, and 
contractile proteins, can all undergo redox sensitive alterations in activity [8]. ROS also exert 
important acute effects on cellular energetics. Chronic changes (that is, over hours and days) in cell 
phenotype result from modulation of intracellular signalling pathways, such as mitogen activated 
protein kinases (MAPKs), and redox sensitive transcription factors (for example, NF-kB, HIF-1, AP-1), 
with consequent alterations in gene and protein expression [9]. Specificity of signalling derives both 
from upstream ligand dependent stimulation of ROS production by different enzymatic sources and the 
targeting of specific downstream pathways by ROS. A wide variety of genes are redox sensitive 
through the above pathways, depending upon the context—for example, VCAM-1, MCP-1, PAI-1, and 
PDGF during endothelial cell activation [7]. 
3. Antioxidants in Redox Status 
In recent years there is an upsurge in the areas related to newer developments in prevention of 
disease especially the role of free radicals and antioxidants. ‘Antioxidants’ are substances that 
neutralize free radicals or their actions. Nature has endowed each cell with adequate protective 
mechanisms against any harmful effects of free radicals: superoxide dismutase (SOD), glutathione 
peroxidase, glutathione reductase, thioredoxin, thiols and disulfide bonding are buffering systems in 
every cell. α-Tocopherol (vitamin E) is an essential nutrient which functions as a chain-breaking 
antioxidant which prevents the propagation of free radical reactions in all cell membranes in the 
human body. Ascorbic acid (vitamin C) is also part of the normal protecting mechanism. Other   
non-enzymatic antioxidants include carotenoids, flavonoids and related polyphenols, α-lipoic acid, 
glutathione etc [10]. 
4. Carotenoids as Redox Agents 
There is evidence to suggest that carotenoids act as modulators of intracellular redox status. Their 
ability to function as antioxidants has been known for many years. They are not just “another group of 
natural pigments”, they are substances with very special and remarkable properties that no other group 
of substances possess and that form the basis of their many, varied functions and actions in all kinds of 
living organisms. The conjugated double bond structure is primarily responsible for the ability of  
β-carotene to quench singlet oxygen physically without degradation, and for the chemical reactivity of 
β-carotene with free radicals such as the peroxyl, hydroxyl, and superoxide radicals. Carotenoids have 
been shown to be able to prevent or decrease oxidative damage to DNA, lipid and proteins [11,12]. 
Conversely, according to Amengual et al., carotenoids can impair respiration and induce oxidative 
stress in β,β-carotene-9',10'-oxygenase (BCDO2)-deficient mice and in human cell cultures [13] 
possibly acting as pro-oxidants and increasing the total radical yield in a system [14]. The key factor to 
determine the switch of carotenoids from antioxidant to pro-oxidant is the oxygen partial pressure (pO2) 
and the carotenoid concentration [15,16]. At higher pO2 a carotenoid radical can react with molecular 
oxygen to generate a carotenoid- peroxyl radical which can act as pro-oxidant by promoting oxidation 
of unsaturated lipids.  Molecules 2012, 17 4758 
 
4.1. Structure of Carotenoids 
The carotenoids are isoprenoid compounds, biosynthesized by tail-to-tail linkage of two C20 
geranylgeranyl diphiosphate molecules. This produces the parent C40 carbon skeleton from which all 
the individual variations are derived. The carotenoids basic structure and numbering scheme is 
illustrated in Figure 1. The most striking and characteristic feature of carotenoid structure is the long 
stem of alternate single and double bonds that forms the central part of the molecule. This constitutes a 
conjugated system in which the п-electrons are effectively delocalized over the entire length of the 
polyene chain. It is the feature that gives the carotenoids as a group their distinctive molecular shape, 
chemical reactivity and light absorbing properties [17]. Among the natural and synthetic carotenoids 
carrying different 5- and 6-membered ring substituents at the end of the conjugated double bond 
system, the location and nature of the substituent at the 6-membered ring had little influence on the 
activity of different carotenoids [18]. Further, the activity of carotenoids differs depending upon the 
size of ring substituents. 
Figure1. Basic chemical structure of carotenoids.  
 
4.2. Bioavailability and Metabolism of Carotenoids 
Several factors influence the absorption of carotenoids. Food processing and cooking that cause 
mechanical breakdown of the tissue releasing the carotenoids improves their absorption [19–21].   
They are absorbed into the gastrointestinal mucosal cells and appear unchanged in the circulation and 
tissues [20–22]. In the intestine the carotenoids are absorbed by passive diffusion after being 
incorporated into the micelles that are formed by dietary fat and bile acids. The micellular carotenoids 
are then incorporated into the chylomicrons and released into the lymphatic system. They are then 
incorporated into the lipoprotein at the site of the liver and released into the blood stream. Carotenoids 
are absorbed differentially by different tissues. The major site of tissue storage of carotenoids is the 
adipose tissue [22,23]. 
5. Cardioprotective Mechanisms of Carotenoids 
5.1. Antioxidant Activity 
Oxidative stress and free radical attack on biological structures are believed to be major factors in 
the initiation and propagation of the development of many degenerative diseases. In general, 
carotenoids behave as effective antioxidants in vitro [24,25] and clear evidence exists from a majority 
of epidemiological studies on the incidence of CVD indicating an inverse relationship with dietary 
carotenoids [26] and circulating carotenoid levels. Carotenoids may function as chain breaking Molecules 2012, 17 4759 
 
antioxidants reducing lipid peroxidation of such vulnerable membranes. The antioxidant properties of 
carotenoids are primarily associated with their ability to quench singlet oxygen [27,28] and scavenge 
free radicals [29–32]. In carotenoids the conjugated carbon double-bond system is considered to be the 
single most important factor in energy transfer reactions, such as those found in photosynthesis [33].  
It is this feature of the molecule that also permits the quenching of singlet oxygen (
1O2). In vitro 
studies have shown that carotenoids are efficient quenchers of singlet oxygen, directly scavenge free 
radicals, and inhibit lipid peroxidation [34]. They exhibit considerable differences in the rate of 
quenching singlet oxygen, with lycopene having the strongest quenching ability of those studied, 
followed by α-carotene,  β-carotene, zeaxanthin, lutein, and β-cryptoxanthin [35]. Lycopene has 
significant antioxidant potential in vitro and has been hypothesized to play a prominent role in 
preventing CVD [36–38]. In this sense, the antioxidant activity of some carotenoids during radical 
peroxide-induced cholesterol oxidation was investigated by Palozza and co-workers [39], showing that 
carotenoids exerted a significant antioxidant activity, in the decreasing activity order indicated: 
astaxanthin, cantaxanthin, lutein and β-carotene. Astaxanthin and canthaxanthin are scavengers of free 
radicals, chain-breaking antioxidants and potent quenchers of reactive oxygen and nitrogen species 
including singlet oxygen, single and two electron oxidants [40–42]. They (astaxanthin and 
canthaxanthin) have terminal carbonyl groups that are conjugated to a polyene backbone [42] and are more 
potent antioxidants and scavengers of free radicals than carotene carotenoids such as β-carotene [42–44]. 
For these reasons dietary supplementation with astaxanthin has the potential to provide antioxidant 
protection of cells and from atherosclerotic cardiovascular disease [45]. McNulty et al., studied the 
differential effects of carotenoids on lipid peroxidation due to membrane interactions. The results 
indicated that the distinct effects of carotenoids on lipid peroxidation are due to membrane structure 
changes [46]. These contrasting effects of carotenoids on lipid peroxidation may explain differences in 
their biological activity. Wilhelmstahl et al., have stated that the ring system of the carotenoids plays a 
role with respect to biological effects on intracellular communication [47]. 
5.2. Hypocholesterolemic Activity 
Although the evidence for a relationship between LDL oxidation and the risk of ischemic heart 
disease and CVD is not fully established, LDL oxidation is now recognized as representing an 
important early event in the development of cardiovascular diseases. Oxidised LDL acts as a trigger to 
initiate endothelial inflammation leading to atherosclerosis and vascular thrombosis (heart attack and 
stroke) [1]. It was proposed that carotenoids may work by inhibiting cholesterol synthesis through the 
regulation of 3-hydroxy-3-methylglutaryl coenzyme a (HMGCoA) reductase [38]. Early in vitro 
studies of LDL oxidation showed that β-carotene carried in LDL is oxidized prior to the onset of 
oxidation of LDL polyunsaturated fatty acids, suggesting a possible role in delaying the onset of LDL 
oxidation [48]. On copper-mediated oxidation of the LDL, the carotenoids were destroyed before 
substantial amounts of lipid peroxidation products were formed, providing further evidence that these 
pigments may be working as antioxidants [49]. β-Carotene reacts with peroxyl radicals to give a 
carbon-centered carotenyl radical which, is similar to lipid free radical, in the presence of oxygen 
produces β-carotene peroxyl radical, so that chain propagation may occur [50]. Carotenoids have been 
shown to inhibit in vivo lipid peroxidation processes, by which the presence of carotenoids in cell Molecules 2012, 17 4760 
 
membranes is essential to act as stabilizing elements of these structures [51]. Several authors have 
published that daily dietary β-carotene supplementation in mammals led to decreased plasma levels of 
total lipids, cholesterol and triglycerides. In a coculture model of the arterial wall, Dwyer et al. [52] 
found lutein to be highly effective in reducing oxidation of low density lipoproteins (LDL) and 
inhibiting the inflammatory response of monocytes to LDL trapped in the artery wall. They also found 
that dietary supplementation with lutein in two mouse models (apoE-null mice and LDL receptor-null 
mice) reduced plasma lipid hydroperoxides and the size of aortic lesions [52]. With in vitro 
experiments of human LDL, lutein and zeaxanthin have been shown to act as scavengers of 
peroxynitrite radicals [53], the product of the reaction between nitric oxide and superoxide. Further, 
Fuhrman and team [37] showed that the addition of lycopene to macrophage cell lines decreased 
cholesterol synthesis and increased LDL receptors. Incubation with lycopene in vitro resulted in a 73% 
decrease in cholesterol synthesis, which was greater than that achieved with β-carotene. 
Epidemiological evidence suggests that a high dietary intake of β-carotene decreases the risk for 
atherosclerotic vascular disease, raising the possibility that lipid-soluble antioxidants slow vascular 
disease by protecting LDL from oxidation. All trans-β-carotene inhibits atherosclerosis in 
hypercholesterolemic rabbits, possibly via stereospecific interactions with retinoic acid receptors in the 
artery wall [54]. 
5.3. Antiinflammatory Activity 
The NF-κB inflammatory pathway has been shown to be partially regulated by ROS and has been 
implicated in various forms of CVD. It is now well recognized that atherosclerosis is an inflammatory 
disease [55], and there is some evidence to suggest that the beneficial effects of lycopene may result 
from modulation of inflammatory responses. Lycopene inhibited LPS-induced production of nitric 
oxide (NO) and interleukin-6 (IL-6) with decreased mRNAs of inducible nitric oxide synthase and  
IL-6 but had no effect on TNF-α. Further study showed that lycopene also inhibited LPS-induced  
IκB phosphorylation, IκB degradation, and NF-κB translocation. Moreover, lycopene blocked the 
phosphorylation of ERK1/2 and p38 MAP kinase but not c-Jun NH2-terminal kinase [56]. Riso et al. [57] 
have reported that concentrations of the proinflammatory cytokine tumor necrosis factor-α (TNF-α) in 
the blood of healthy volunteers were decreased after dietary supplementation with a tomato-based 
drink. Napolitano et al. [58] showed that lycopene may reduce macrophage foam cell formation in 
response to modified LDL by decreasing lipid synthesis in the cells and down regulating the activity 
and expression of SR-A. These potentially beneficial effects, however, are accompanied by a marked 
decrease in the secretion of the anti-inflammatory cytokine IL-10, resulting in an increase in the 
proinflammatory profile of macrophage cytokine release. Lutein exerts potent antioxidant and anti-
inflammatory effects in aortic tissue that may protect against development of atherosclerosis in guinea 
pigs [59]. Inflammatory mediators such as TNF-α and interleukins IL-1β, and IL-8, enhance binding of 
low-density lipoprotein (LDL) to endothelium and upregulate expression of leukocyte adhesion 
molecules on endothelium during atherogenesis. Another study examined the effects of different levels 
of dietary lutein and fat on LPS-induced iNOS mRNA levels in chicken macrophages. It was 
concluded in the study that lutein and fat or EPA act through the PPARγ and RXR pathway to change 
iNOS expression, and that this effect is dependent on the dose of lutein and fat or EPA [60].  Molecules 2012, 17 4761 
 
Several studies have suggested an anti-inflammatory response of lycopene. Investigations on the 
effect of lycopene on inflammation using oil-induced ear edema in male Kingming mice, a common 
screening method for determining anti-inflammatory activity are impressive [61]. Lycopene, given as 
tomato oleoresin, was most effective against inflammation at a dose of 0.5 g/kg body weight   
(p < 0.05). Interestingly, the inhibitory effects that occurred with a dose of 0.1 g lycopene/kg body 
weight were similar to those in the control group using the anti-inflammatory drug amoxicillin   
at the same dosage. Ohgami et al. [62] demonstrated multiple effects of intravenous astaxanthin 
administration in a uveitis model in rats, including anti-inflammatory [reductions in levels of nitric 
oxide (NO), tumor necrosis factor alpha (TNF-α), and prostaglandin E2 (PGE2)] and direct   
enzyme-inhibiting activity (against inducible nitric oxide synthase, iNOS). Another pathway in which 
astaxanthin combats inflammation is through inhibition of the cyclooxygenase enzymes (Cox-1 and 
Cox-2). In one experiment done with mice and also in-vitro, astaxanthin was shown to suppress TNF-α, 
PGE-2, IL-1β, NO as well as the Cox-2 enzyme and nuclear factor kappa-B [63].  
6. Role on Endothelial Function  
An imbalance of reduced production of NO and increased production of reactive oxygen species 
may be involved in impaired endothelium-dependent vasodilation in patients with cardiovascular risk 
factors and diseases. In the vascular endothelium, the free radical NO• is produced from arginine by 
nitric oxide synthase (NOS), converting the substrate L-arginine to L-citrulline: 
L-Arg + O2 + NADPH    
NOS    N→O• + citrulline 
The reaction requires calmodulin, NADPH and tetrahydrobiopterin (BH4) as cofactors. Under 
normal conditions, NO• is protective against adhesion of platelets and leucocytes, anti-inflammatory, 
anti-proliferative and regulates the expression and synthesis of extracellular matrix proteins. 
It inhibits redox sensitive transcription factor, NFκβ expression through its binding with IKβ, linked 
to a number of diseases which shorten life. Oxidative damage to cholesterol component of the   
low-density lipoprotein (LDL) leads to oxidised LDL by a series of consecutive events. This induces 
endothelial dysfunction, which promotes inflammation during atherosclerosis [64]. Carotenoids and 
vitamins could have an antioxidant-mediated tempering influence on endothelial function and 
inflammation, thereby reducing the risk of atherosclerosis [65]. Martin et al. [66] tested carotenoid 
effects on vascular endothelium using human aortic endothelial cell cultures. Preincubation of 
lycopene resulted in a 13% decreased expression of the vascular cell adhesion molecule, a molecule 
present on activated endothelial tissues that aids in the recruitment of leukocytes. Enhanced production 
of tissue factor has been linked to development of cardiovascular disease due to endothelial activation, 
resulting in thrombosis of blood vessels. Akt-specific inhibitor reversed the inhibitory effect of 
carotenoids on tissue factor activity, indicating that carotenoids enhanced phosphorylation of Akt and 
suppressed tissue factor activity in endothelial cells by this mechanism [67].  Molecules 2012, 17 4762 
 
Figure 2. Schematic representation of carotenoids’ action on CVD.  
 
7. Influence on Gap Junction Communication 
Gap junction proteins called connexins mediate gap junction intercellular communication (GJC) 
and are a group of ≥20 highly conserved proteins with developmental and tissue-specific expression 
patterns. GJC allows the direct transmission among neighboring cells of ions, small hydrophilic 
metabolites, and messengers <1–2 kDa in size. GJC play an important role in normal development and 
physiology, with a loss of function implicated in various human diseases and pathologies. In the heart, 
electrical activation of the myocardium is necessary to produce effective pumping of blood and 
depends on the orderly coordinated spatial and temporal transfer of current (ions) from one cell to 
another [68]. In normal ventricular myocytes, this is accomplished through extensive cell-cell coupling 
via gap junctions. Cells have the capacity to rapidly regulate the function (posttranslational regulation), 
quantity (transcriptional regulation), and composition (assembly regulation) of connexins within the 
gap junctional structures to accommodate physiologic demands for altered cell-cell communication. 
Specifically, connexin 43 is the most ubiquitously expressed connexin in tissues and is essential for 
normal cardiac function and contraction. There has been considerable interest in the increase in gap 
junction communication (GJC) with carotenoids, especially lycopene, as it relates to cancer [69]. 
Optimal communication between endothelial cells in the artery walls is also desirable; this 
enhancement of GJC by lycopene may help maintain an intact and healthy endothelial surface of Molecules 2012, 17 4763 
 
arteries. A well-established role of carotenoids as modulators of connexin 43 production and 
maintenance and/or restoration of gap junctional communication in mammals [70], suggest a multi-
factorial influence of astaxanthin in cardioprotection. Several carotenoids have been shown to 
upregulate connexin 43 protein levels and GJC [71].  
8. Attenuation of Ischemia-Reperfusion Injury 
Ischemia-reperfusion (I/R) injury is a complex phenomenon, generally attributed to the additional 
damage produced by reintroduction of oxygenated blood flow to a previously ischemic area. It is well 
established that cell death during (I/R) occurs via necrotic and apoptotic pathways [72] causing much 
damage to the heart. It has been shown that the mitogen-activated protein kinases (MAPKs), PKB/Akt 
and the NO-cGMP all play vital roles in ischemia/reperfusion injury in the heart. Hence, two teams 
worked on the role of red palm oil (RPO), carotenoid rich oil on ischemic reperfusion injury. From the 
results of the two teams it is evident that two pathways may play a role in the protection induced by 
RPO against ischemia/reperfusion injury [73,74]. The results of Esterhuyse et al. show that protection 
may occur during ischemia and that NO-cGMP may be involved. Engelbrecht et al. on the other hand, 
argue for a role of the PKB/Akt and the MAP kinases pathways in the cardioprotective effects of RPO 
during reperfusion. Similarly, cardioprotection and myocardial salvage by a disodium disuccinate 
astaxanthin derivative, Cardax was studied. Significant myocardial salvage is reported for the first 
time in that study for a novel carotenoid derivative which generates non-esterified, free astaxanthin 
after parenteral administration in vivo [75]. The mechanism(s) of action of carotenoids, and in 
particular astaxanthin, in cardioprotection have not been well characterized. However, Aoi and 
members of his lab identified that astaxanthin limits exercise-induced skeletal and cardiac muscle 
damage in mice [76]. It is also demonstrated that there is excellent accumulation of non-esterified,  
free astaxanthin in rodent myocardium after chronic oral administration of esterified, natural source  
of astaxanthin [77]. A dose-dependent cardioprotective effect was seen in their ROS mediated   
strenuous exercise injury model, with antioxidant and anti-inflammatory [i.e., reduction of tissue 
myeloperoxidase (MPO) levels] effects observed in that seminal study. Lutein inhibited LPS- and 
H2O2-induced increases in phosphatidylinositol 3-kinase (PI3K) activity, PTEN inactivation,   
NF-κB-inducing kinase (NIK), and Akt phosphorylation, which are all upstream of IκB kinase (IKK) 
activation, but did not affect the interaction between Toll-like receptor 4 and MyD88 and the activation 
of mitogen-activated protein kinases. The study suggested that H2O2 modulates IKK-dependent NF-κB 
activation by promoting the redox-sensitive activation of the PI3K/PTEN/Akt and NIK/IKK   
pathways [78]. (I/R) causes cardiomyocyte death by activating death signals and/or inhibiting survival 
signals by redox signaling pathways [79]. The ability of lycopene in inhibiting IL-8 production,   
NF-kB/p65 nuclear translocation, and redox signalling and in increasing PPARγ expression was also 
found in isolated rat alveolar macrophages exposed to cigarette smoking extract [80]. 
9. Conclusions 
More and more evidence indicates that a proper balance between oxidants and antioxidants is 
involved in maintaining health and longevity and that altering this balance in favor of oxidants may 
result in pathological responses causing functional disorders and disease. Epidemiologic research on Molecules 2012, 17 4764 
 
nutrition demonstrates that those who consume higher amounts of fruits and vegetables tend to have 
comparatively lower rates of heart and vascular diseases, including coronary heart disease and stroke. 
Short-term dietary intervention trials suggest that diets rich in fruit and vegetable intake lead to 
improvements in coronary risk factors and reduce cardiovascular mortality. Carotenoids are abundant, 
plant-derived, fat-soluble pigments that can function as antioxidants. Although more than 600 
carotenoids have been identified, the majority of research in nutrition has focused on the five most 
common carotenoids: α-carotene,  β-carotene, lycopene, lutein/zeaxanthin, and β-cryptoxanthin. 
Carotenoids may prevent heart and vascular disease in a number of ways as discussed earlier and 
summarized in Figure 2. For these reasons, carotenoids from plants may represent one plausible 
mechanism by which fruits and vegetables reduce the risk of CVD. 
Historically, carotenoids have been known to have important beneficial properties for human health. 
Their biological role in the prevention and perhaps the treatment of heart and vascular diseases is now 
being studied and understood. Epidemiological and other population studies have shown the 
importance of these phytochemicals in the prevention of human diseases. In vitro and animal studies 
have tested the hypothesis generated from the epidemiological observations. Although some human 
clinical trials are beginning to be undertaken there is a great need for well-designed human 
intervention studies that take into consideration study designs including subject selection, end point 
measurements and the levels of carotenoids being tested. It is only through such studies that our 
understanding of the important role played by carotenoids will be enhanced and help us develop 
complementary strategies for the prevention, treatment and management of diseases. 
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